ARL9
ADP-ribosylation factor-like protein 9
Also known as: ARL9_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6T311
- Gene
- ARL9
- Ensembl
- ENSG00000196503
- Chromosome
- 4
- Canonical length
- 187 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Centriolar satellite,Cytosol
OverviewNCBI Gene
ARL9 is a member of the small GTPase protein family with a high degree of similarity to ARF (MIM 103180) proteins of the RAS superfamily.[supplied by OMIM, Nov 2008]
Canonical amino-acid sequenceUniProt
187 residues, UniProt reviewed canonical sequence.
>Q6T311|ARL9
1 MRPTWKALSH PAWPEEKNKQ ILVLGLDGAG KTSVLHSLAS NRVQHSVAPT QGFHAVCINT
61 EDSQMEFLEI GGSKPFRSYW EMYLSKGLLL IFVVDSADHS RLPEAKKYLH QLIAANPVLP
121 LVVFANKQDL EAAYHITDIH EALALSEVGN DRKMFLFGTY LTKNGSEIPS TMQDAKDLIA
181 QLAADVQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARL9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 11 nTPM
- testis: 8.3 nTPM
- bone marrow: 2.1 nTPM
- basal ganglia: 1.8 nTPM
- skin: 1.7 nTPM
- cerebral cortex: 1.6 nTPM
Single-cell type
- late spermatids: 443 nCPM
- early spermatids: 113 nCPM
- late primary spermatocytes: 98 nCPM
- retinal pigment epithelial cells: 60 nCPM
- pituicytes/fscs: 34 nCPM
- gastric progenitor cells: 28 nCPM
Immune cell
- plasmacytoid DC: 0.3 nTPM
- memory CD4 T-cell: 0.2 nTPM
- naive CD4 T-cell: 0.2 nTPM
- T-reg: 0.2 nTPM
- memory CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- choroid plexus: 10 nTPM
- medulla oblongata: 5 nTPM
- hypothalamus: 3.6 nTPM
- cerebellum: 3.3 nTPM
- midbrain: 3.3 nTPM
- pons: 3.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.86
- gnomAD pLI
- 0.44
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARL9 as an antibody target. Whether an autoantibody or antibody against ARL9 could matter depends on whether native ARL9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARL9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARL9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...